Ernexa Therapeutics Income Statement (2010-2026) | ERNAW

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Revenue & cost
Revenue (Quarter)										0.05M	0.05M	0.05M	0.05M	0.49M	0.02M
Gross Profit (Quarter)								-0.05M		-0.07M	-0.05M	-0.01M	-0.05M	0.55M	0.00M
Operating items
Depreciation & Amortization - Total (Quarter)
Research & Development (Quarter)	5.43M	1.49M	4.25M	1.78M	1.69M	3.50M	1.96M	1.67M	1.50M	1.39M	1.36M	1.46M	0.99M	1.00M	1.16M	1.31M	1.14M	1.03M	0.68M	1.92M
Selling, General & Administrative (Quarter)	4.58M	4.25M	4.27M	4.51M	6.21M	3.34M	2.77M	3.59M	2.59M	4.05M	4.36M	4.32M	3.90M	3.38M	1.54M	1.42M	1.36M	0.96M	1.42M	1.63M
Other Operating Expenses (Quarter)	-0.05M								0.46M					1.58M						2.04M
Operating Expenses (Quarter)	10.01M	86.28M	8.52M	6.30M	13.88M	8.30M	4.74M	5.27M	4.55M	5.44M	5.72M	5.77M	4.88M	2.81M	2.70M	2.73M	2.50M	1.99M	2.09M	5.59M
Operating Income (Quarter)	-10.01M	-86.28M	-8.52M	-6.30M	-13.88M	-8.30M	-4.74M	-5.32M	-4.55M	-5.50M	-5.76M	-5.79M	-4.93M	-2.26M	-2.70M	-2.73M	-2.50M	-1.99M	-2.09M	-5.59M
EBIT (Quarter)	-10.01M	-86.28M	-8.52M	-6.30M	-13.88M	-8.30M	-4.74M	-5.32M	-4.55M	-5.50M	-5.76M	-5.79M	-4.93M	-2.26M	-2.70M	-2.73M	-2.50M	-1.99M	-2.09M	-5.59M
Non-operating items
Interest & Investment Income (Quarter)								0.00M	0.02M	-0.11M	0.23M	-0.79M	-0.80M	-1.69M	3.52M	0.01M		0.03M	-0.06M	0.04M
Other Non Operating Income (Quarter)	-0.02M	0.29M	0.63M	-1.14M	-0.01M	-0.01M	0.03M	0.00M	-0.28M	-0.00M	-0.05M			-22.44M	22.51M	-0.14M	-0.12M	-0.01M	-0.52M
Non Operating Income (Quarter)	-0.02M	0.29M	0.63M	-3.08M	10.48M	0.99M	0.29M	-0.10M	0.04M	-0.00M	-0.39M	-0.86M	-0.59M	-24.33M	25.85M	-0.14M	-0.12M	-0.01M	0.53M	0.04M
Net income details
EBT (Quarter)	-10.01M	-85.99M	114.59M	-9.38M	-3.40M	-7.31M	-4.45M	-5.41M	-4.50M	-5.60M	-6.14M	-6.64M	-5.53M	-26.59M	38.78M	-8.19M	-3.14M	-1.23M	-1.56M	-5.55M
Tax Provisions (Quarter)			0.06M			0.01M	-0.00M	0.01M	0.00M	-0.01M	-0.00M	0.00M	0.00M	0.01M	-0.02M	0.01M	0.00M	0.01M	-0.01M	-0.04M
Profit After Tax (Quarter)	-10.09M	-85.99M	-7.95M	-9.38M	-3.40M	-7.32M	-4.49M	-5.42M	-4.51M	-5.59M	-6.15M	-6.65M	-5.53M	-26.60M	-5.76M	-8.20M	-3.14M	-1.24M	-1.50M	-5.50M
Income from Continuing Operations (Quarter)	-10.01M	-85.99M	114.52M	-9.38M	-3.40M	-7.32M	-4.45M	-5.42M	-4.51M	-5.59M	-6.14M	-6.65M	-5.53M	-26.60M	38.80M	-8.20M	-3.14M	-1.24M	-1.55M	-5.51M
Consolidated Net Income (Quarter)	-10.01M	-85.99M	114.52M	-9.38M	-3.40M	-7.32M	-4.45M	-5.42M	-4.51M	-5.59M	-6.14M	-6.65M	-5.53M	-26.60M	38.80M	-8.20M	-3.14M	-1.24M	-1.55M	-5.51M
Income towards Parent Company (Quarter)	-10.01M	-85.99M	114.52M	-9.38M	-3.40M	-7.32M	-4.45M	-5.42M	-4.51M	-5.59M	-6.14M	-6.65M	-5.53M	-26.60M	38.80M	-8.20M	-3.14M	-1.24M	-1.55M	-5.51M
Preferred Dividend Payments (Quarter)	0.01M		0.01M		0.01M		0.01M		0.01M		0.01M		0.01M		0.01M		0.01M		0.01M
Net Income towards Common Stockholders (Quarter)	-10.09M	-85.99M	-7.96M	-9.38M	-3.41M	-7.32M	-4.50M	-5.42M	-4.52M	-5.59M	-6.16M	-6.65M	-5.54M	-26.60M	-5.77M	-8.20M	-3.15M	-1.24M	-1.51M	-5.51M
Additional items
EPS (Basic) (Quarter)	-0.24	-34.03	0.18	-3.50	-1.16	-2.49	-1.02	-1.06	-0.85	-1.03	-1.14	-1.23	-15.34	-73.70	58.49	-57.76	-0.61	-0.15	-0.01	-6.95
EPS (Weighted Average and Diluted) (Quarter)	-0.24	-34.03	0.18	-3.50	-1.16	-2.49	-1.02	-1.06	-0.85	-1.03	-1.14	-1.23	-15.34	-73.70	58.49	-57.76	-0.61	-0.15	-0.01	-6.95
Shares Outstanding (Weighted Average) (Quarter)	35.19M	2.53M		6.86M	2.94M	2.85M	3.05M	0.00M	5.30M	5.28M	1.26M	0.02M	0.36M	0.36M	0.91M	1.61M	4.35M	0.41M	0.02M	0.86M
Shares Outstanding (Diluted Average) (Quarter)	35.19M	2.02M	2.17M	2.68M	2.94M	2.85M	3.05M	5.13M	5.21M	5.41M	5.31M	5.41M	0.36M	0.36M	0.91M	0.14M	4.35M	5.66M	6.31M	0.79M
EBITDA (Quarter)	-10.01M	-86.28M	-8.52M	-6.30M	-13.88M	-8.30M	-4.74M	-5.32M	-4.55M	-5.50M	-5.76M	-5.79M	-4.93M	-2.26M	-2.70M	-2.73M	-2.50M	-1.99M	-2.09M	-5.59M
Interest Expenses (Quarter)					0.01M	0.01M	-1.14M		0.26M	0.11M	0.24M
Shares Outstanding (Quarter)	2.23M	2.60M	2.60M	0.16M	0.16M	2.94M	5.13M	0.16M	5.41M	5.41M	0.36M	0.16M	0.36M	0.36M	0.16M	0.16M	7.48M	7.85M	0.16M	1.17M
Tax Rate (Quarter)			0.06			-0.07	0.02	-0.09	-0.09	0.14	0.07	-0.06	-0.05	-0.05	-0.04	-0.10	-0.10	-0.49	0.90	0.72

Research Tools

Developers

Ernexa Therapeutics Income Statement (2010-2026) | ERNAW

Research Tools

Developers

Ernexa Therapeutics Income Statement (2010-2026) | ERNAW

Create an account

Sign In

Reset Password